Boehringer Ingelheim and Lilly Alliance
Boehringer Ingelheim and Eli Lilly and Company have an alliance that centres on disease areas of diabetes and heart failure. By joining forces, the companies demonstrate their commitment in the improvement of patient care to address the areas of unmet medical need.
